Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Blocking Prostaglandin D₂ may help treat hair loss.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Finasteride reduces movement issues in Parkinson's disease rats.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Dutasteride may protect the brain in early Parkinson's disease.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Finasteride reduces gambling symptoms in Parkinson's patients.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

DPP may help hair regrowth by improving blood vessel function under stress.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

PDRN helps repair tissue and improve wound healing with a high safety profile.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.